Publicaciones en las que colabora con José Antonio Egido Rodríguez (124)

2024

  1. Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study

    Neurologia, Vol. 39, Núm. 3, pp. 226-234

2023

  1. Mechanical thrombectomy is cost-effective versus medical management alone around Europe in patients with low ASPECTS

    Journal of NeuroInterventional Surgery, Vol. 15, Núm. 7, pp. 629-633

2021

  1. Safety and Outcomes of Thrombectomy in Ischemic Stroke With vs Without IV Thrombolysis

    Neurology, Vol. 97, Núm. 8, pp. e765-e776

  2. Safety and outcomes of routine endovascular thrombectomy in large artery occlusion recorded in the SITS Register: An observational study

    Journal of Internal Medicine, Vol. 290, Núm. 3, pp. 646-654

  3. Stroke etiology and outcomes after endovascular thrombectomy: Results from the SITS registry and a meta-analysis

    Journal of Stroke, Vol. 23, Núm. 3, pp. 388-400

  4. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2020

  1. Management of Large Vessel Occlusion Stroke Related to Infective Endocarditis: Is Mechanical Thrombectomy a Safe Option?

    Journal of Stroke and Cerebrovascular Diseases, Vol. 29, Núm. 11

  2. Mechanical Thrombectomy in Medium Vessel Occlusions: Blind Exchange With Mini-Pinning Technique Versus Mini Stent Retriever Alone

    Stroke, Vol. 51, Núm. 11, pp. 3224-3231

  3. Use of intracranial stent as rescue therapy after mechanical thrombectomy failure—9-year experience in a comprehensive stroke centre

    Neuroradiology, Vol. 62, Núm. 11, pp. 1475-1483

2019

  1. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry

    JAMA Cardiology, Vol. 4, Núm. 6, pp. 526-548

  2. Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry

    Journal of the American Heart Association, Vol. 8, Núm. 3

  3. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    American Heart Journal, Vol. 213, pp. 35-46

  4. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry

    Clinical Cardiology, Vol. 42, Núm. 5, pp. 553-560

  5. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Cardiovascular health in an Ecuadorian migrant population to Madrid (Spain). Should we worry?

    Revista Ecuatoriana de Neurologia, Vol. 27, Núm. 3, pp. 16-19

  2. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry

    European Heart Journal, Vol. 39, Núm. 6, pp. 464-473

  3. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335

  4. Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry

    Neurologia, Vol. 33, Núm. 7, pp. 419-426

  5. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

    PLoS ONE, Vol. 13, Núm. 1

  6. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835